Indeed, the sensitivity of some multiple myelomas to JQ1 arises in part from a similar loss of Myc expression in cases where translocated MYCC coding sequences are juxtaposed to the IgH enhancer, which also binds BRD4 [23]. This evidence concerns the gene BRD4 and plasma cell myeloma.